SNAI2 and breast carcinoma: TBX3 and SNAI2 mRNA levels were significantly lower in high‐grade breast cancers than in low‐ and intermediate‐grade breast cancers (Figure 5D) (p < 0.001), consistent with our immunohistochemical data.